Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 500 | 1,970 |
| Receivables | 0 | 0 | 0 | 30 | 30 |
| Other current assets | 0 | 0 | 0 | 20 | 50 |
| TOTAL | $0 | $0 | $0 | $550 | $2,050 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 260 | 260 |
| Other Non-Current Assets | 0 | 0 | 0 | 130 | 280 |
| TOTAL | $N/A | $N/A | $N/A | $390 | $540 |
| Total Assets | $0 | $0 | $0 | $690 | $2,340 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 10 | 100 |
| Accrued Expenses | 0 | 0 | 0 | 480 | 560 |
| Other current liabilities | 0 | 0 | 0 | 40 | 30 |
| TOTAL | $0 | $0 | $0 | $2,570 | $740 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | -41 | -58 | -59 | 0 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $0 | $0 | $0 | $2,570 | $740 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | 0 | 2 | 2 |
| Retained earnings | 0 | 0 | 0 | -55,080 | -51,200 |
| Other shareholders' equity | 0 | 0 | 0 | 42,828 | 42,598 |
| TOTAL | $0 | $0 | $0 | $-1,870 | $1,590 |
| Total Liabilities And Equity | $0 | $0 | $0 | $700 | $2,330 |